AbbVie to Buy Pharmacyclics in $21 Billion Deal

Related Link: 

AbbVie said it will buy cancer biotech Pharmacyclics in a $21 billion deal that returns the Chicago drug company to deal-making after backing away from a big tax-lowering takeover last year.

Crafts Site Etsy Files for Initial Offering

Related Link: 

Etsy unveiled plans to further test investors’ appetite for e-commerce companies, filing for an initial public offering a decade after it was founded in a Brooklyn, N.Y., apartment as a way to sell handmade goods online.

Handbag Prices Begin to Hit Their Limit

Related Link: 

For years, prices of high-end handbags rose sharply, but now even wealthy buyers are pushing back. As a result, design houses including Gucci, Fendi, Prada and Mulberry are adding lower-price items.

Business Schools Teach Networking, American Style

Related Link: 

A handful of business schools are helping international students master the art of introductory email and informal networking—with some help from Jim Carrey.

Oil Companies Begin to Give Up on Yemen

Related Link: 

The political upheaval in Yemen has dealt a powerful blow to the country’s oil industry, forcing companies to abandon productive oil patches and evacuate staff as a rebel group consolidates power.

Foxconn Launches New E-Commerce Platform in China

Related Link: 

The world’s biggest contract electronics manufacturer, Foxconn, is making a move into e-commerce in China, aiming to go head-to-head with the likes of Alibaba and JD.com.

American Eagle Shows Strength Among Teens

Related Link: 

American Eagle reported its first quarter of year-over-year revenue growth in two years, boosted by a new line of one-size-fits-all clothes, while teen apparel rival Abercrombie & Fitch continued to struggle.

U.S. Refiners, Striking Workers Digging In for Protracted Battle

Related Link: 

U.S. refiners and striking union workers are digging in for a protracted battle that could last through the spring.

FDA Approves Bristol-Myers Drug for Lung Cancer

Related Link: 

U.S. regulators approved Bristol-Myers Squibb’s advanced lung cancer drug Opdivo, ithe latest of a string of events that has the oncology world riveted on efforts to enlist the body’s immune system to fight the disease.

Simon Property Makes Takeover Approaches to Macerich

Related Link: 

Simon Property Group Inc. has made takeover approaches for rival Macerich Co., seeking to combine two of the largest shopping-mall owners in the U.S.

Syndicate content